Mariana Chavez Mac Gregor

Has grant

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mariana Chavez Mac Gregor is a Professor at The University of Texas MD Anderson Cancer Center in the United States. Her research encompasses various aspects of breast cancer, including innovative prognostic systems, treatment patterns for early-stage and metastatic cases, and the impact of family dynamics on patient care. She is also actively involved in developing guidelines to enhance the professional fulfillment of academic oncologists and addressing ethical communication strategies in oncology.

Recent Grants

Grant: Close

Cancer Care Delivery and Breast Cancer: Impact and Associated Factors

Open Date: 2023-10-01

Close Date: 2024-09-30

Grant: Close

Treatment non-completion among patients with breast cancer: impact and associated factors.

Open Date: 2022-10-01

Close Date: 2023-09-30

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (6)

Lajos Pusztai

Yale University

UNITED STATES

View details

Corey W. Speers

University of Michigan

UNITED STATES

View details

Matthew Goetz

Professor of Oncology and Pharmacology

Mayo Clinic

UNITED STATES

View details

Richard Lee

City of Hope

UNITED STATES

View details

Patricia Ganz

Professor

University of California, Los Angeles

UNITED STATES

View details

Xiudong Lei

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mariana Chavez Mac Gregor

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Novel Postneoadjuvant Prognostic Breast Cancer Staging System

Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers

Use of adjuvant capecitabine in older patients with early-stage triple-negative breast cancer

Treatment Patterns, Trends, and Outcomes of Neoadjuvant Chemotherapy Use Among Patients With Early-Stage Invasive Triple-Negative Breast Cancer

Parenting and Family Concerns of Couples Navigating Advanced Breast Cancer: Exploring Discussions Around Parenting Challenges and Targets for Intervention

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Ethics of Patient-Clinician Boundaries in Oncology: Communication Strategies for Promoting Clinician Well-Being and Quality Patient Care

Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline

Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis

Significance of Pathologic Response in Patients With Early and Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy in a Middle-Income Country. A Real-World Historical Cohort

Collaborators (6)

Lajos Pusztai

Corey W. Speers

Matthew Goetz

Richard Lee

Patricia Ganz

Xiudong Lei

Make your next move.